Outcomes After Use of Standard- and Low-Dose Non–Vitamin K Oral Anticoagulants in Asian Patients With Atrial Fibrillation-Reference-Cited by-同舟云学术

Outcomes After Use of Standard- and Low-Dose Non–Vitamin K Oral Anticoagulants in Asian Patients With Atrial Fibrillation

Published:2019-01 Issue:1 Volume:50 Page:110-118
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Cho Min Soo¹,Yun Ji Eun²,Park Ji Jeong²,Kim Yun Jung²,Lee Jessie²,Kim Hyungmin³,Park Duk-Woo¹,Nam Gi-Byoung¹

Affiliation:

1. From the Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea (M.S.C., D.-W.P., G.-B.N.)

2. Division for Healthcare Technology Assessment Research, National Evidence-Based Healthcare Collaborating Agency, Seoul, Republic of Korea (J.E.Y., J.J.P., Y.J.K., J.L.)

3. Department of Insurance Benefits, National Health Insurance Service, Korea (H.K.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialised Nursing,Cardiology and Cardiovascular Medicine,Clinical Neurology

Reference33 articles.

1. Worldwide Epidemiology of Atrial Fibrillation

2. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

3. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

4. Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study

5. Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Effectiveness and Safety of Off-Label Underdosed Direct Oral Anticoagulants in Asian Patients with Atrial Fibrillation: A Systematic Review and Meta-analysis;Drug Safety;2024-08-30

2. Clinical characteristics of apixaban prescription in AF patients with single dose-reduction criterion: the ASPIRE (efficAcy and safety of aPixaban in rEal-world practice in Korean frail patients with atrial fibrillation) study;Frontiers in Cardiovascular Medicine;2024-06-10

3. Half-dose direct oral anticoagulation versus warfarin for atrial fibrillation following cardiac surgery;The Journal of Cardiovascular Surgery;2024-05

4. Outcomes of non-vitamin K oral anticoagulants for secondary prevention in ischemic stroke with atrial fibrillation;Scientific Reports;2024-04-29

5. Development and transfer learning of self-attention model for major adverse cardiovascular events prediction across hospitals;2024-04-19